← Back to Search

Behavioral Intervention

MBTI for Insomnia (Project WISHES Trial)

N/A
Waitlist Available
Led By Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 8 and week 16
Awards & highlights

Project WISHES Trial Summary

"This trial aims to improve the health of Black women by using a mindfulness-based sleep intervention to reduce stress and sleep-related health issues."

Who is the study for?
This trial is for Black women who are experiencing insomnia and may have cardiometabolic syndrome, which includes conditions like heart disease and diabetes. Participants should be interested in trying a mindfulness-based therapy to improve their sleep.Check my eligibility
What is being tested?
The study is testing Mindfulness-Based Therapy for Insomnia (MBTI), aiming to reduce stress and the risk of diseases related to poor sleep among participants by teaching them techniques to enhance their sleep quality.See study design
What are the potential side effects?
Mindfulness-based therapy typically does not involve medication, so physical side effects are rare. However, some individuals might experience emotional discomfort as they confront stressful thoughts during practice.

Project WISHES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 8 and week 16
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 8 and week 16 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention (AIM)
Change in Insomnia Severity
Change in Perceived Stress
+2 more

Project WISHES Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MBTIExperimental Treatment1 Intervention
Participants randomized to MBTI group.
Group II: ControlActive Control1 Intervention
Participants randomized to waitlist control group.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mindfulness-based therapy for insomnia (MBTI)
2022
N/A
~30

Find a Location

Who is running the clinical trial?

Yale UniversityLead Sponsor
1,848 Previous Clinical Trials
2,737,478 Total Patients Enrolled
6 Trials studying Insomnia
166 Patients Enrolled for Insomnia
Department of Health and Human ServicesFED
226 Previous Clinical Trials
928,609 Total Patients Enrolled
Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAANPrincipal InvestigatorYale University School of Nursing

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which individuals meet the criteria for participation in this medical study?

"To qualify for participation in this research study, individuals must have a diagnosis of insomnia and be between 18 and 70 years old. The trial aims to enroll a total of 340 participants."

Answered by AI

Are individuals aged 65 and above eligible to participate in this clinical trial?

"To be considered for this research, individuals aged between 18 and 70 are eligible. It is noteworthy that there are a total of 31 investigations targeting participants under the age of majority and another 190 focusing on those above the age of 65."

Answered by AI

Is the enrollment for this research study still ongoing?

"As per clinicaltrials.gov, this specific medical investigation is not currently seeking subjects. It was initially published on September 1st, 2025 and last revised on March 28th, 2024. However, amidst the availability of approximately 245 ongoing studies that are actively recruiting participants at present."

Answered by AI
~227 spots leftby Jul 2028